Privigen 10% vial 200ML
Ended Awarded
- Contract number
- SPE2DB26FDD76
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $34,908
Award facts
- Contract value 100% obligated
- $34,908.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a $34,908 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for the supply of PRIVIGEN 10% Vial 200ML. The award, issued on October 24, 2025, with an ultimate completion date of November 17, 2025, carries no set-aside designation, demonstrating the contractor's competitive capability in unrestricted federal procurement. This delivery order was issued without subcontractors and is funded entirely by the DLA's Medical Supply Chain division.
This delivery order is issued under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract (IDC) with the DLA, designated SPE2DR under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative. The underlying $499.999 billion IDC, awarded on November 13, 2025, positions the contractor as a critical regional pharmaceutical supplier for Department of Defense healthcare operations globally, with a completion date of December 31, 2036. The PPV-G GEN V program represents a $30.3 billion DLA acquisition strategy establishing multiple prime vendor contractors to supply branded and generic prescription drugs, biologics, vaccines, and medical consumables to support recurring medical supply needs of military healthcare facilities worldwide.
Quick answers
Who was awarded contract SPE2DB26FDD76?
SPE2DB26FDD76 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on October 24, 2025.
How much is contract SPE2DB26FDD76 worth?
The government has obligated $34,908 on SPE2DB26FDD76.
Is contract SPE2DB26FDD76 an order under another contract?
Yes. SPE2DB26FDD76 is a delivery order under SPE2DB22D9239, an indefinite delivery contract.
Was contract SPE2DB26FDD76 competed?
The extent of competition for SPE2DB26FDD76 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award